Subdermal Contraceptive Implants Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Subdermal Contraceptive Implants Market Analysis

The Subdermal Contraceptive Implants Market size is estimated at USD 0.92 billion in 2024, and is expected to reach USD 1.12 billion by 2029, growing at a CAGR of 3.97% during the forecast period (2024-2029).

• The COVID-19 pandemic impacted the growth of the studied market. Initially, the global COVID-19 outbreak and the lockdown scenario in various countries had imposed some challenges on the market, as hospitals and clinics were forced to suspend services to prevent the spread of the SARS-CoV-2 virus. For instance, according to the United Nations Population Fund, in March 2021, the COVID-19 pandemic disrupted the family planning services of more than 12.0 million women, resulting in 1.4 million unplanned pregnancies. In addition, during the initial lockdown, women were nine times more likely to have difficulty accessing contraception, resulting in an almost doubling of unexpected births, from 1.3% pre-lockdown to 2.1% post-lockdown.
• Furthermore, according to the research study conducted by the United Nations Sexual and Reproductive Health Agency (UNFPA) in 2021, more than 47.0 million women lost access to contraception, leading to 7.0 million unintended pregnancies as a result of the COVID-19 crisis. Thus, during the initial phase of the pandemic, due to lower access to contraceptives, the market witnessed a negative impact. However, with the ease of restrictions, lockdown upliftments, and decreasing cases of COVID-19, the market started to gain momentum and is expected to continue the upward trend over the forecast period.
• The increasing number of unwanted pregnancies and, thereby, the rising number of initiatives to promote the use of contraceptive methods are the major drivers for the market. The number of unwanted pregnancies is increasing globally, and it is a matter of serious concern all around the world. For instance, according to the United Nations Population Fund, in March 2022, unintended pregnancies accounted for about half of all pregnancies worldwide, with 121.0 million occurring each year. The same source also stated that 60.0% of unplanned pregnancies end in abortion, with an estimated 45.0% of all abortions being unsafe, resulting in 5-13% of all maternal fatalities, putting the world's capacity to meet the Sustainable Development Goals at risk.
• Similarly, according to an article published by the NCBI in June 2021, it has been observed that unplanned pregnancy is one of Ethiopia's biggest reproductive health issues, with all of its negative consequences. Every year, on average, 4.93 million pregnancies occur, with 1.9 million Ethiopian women (38%) having an unintended pregnancy, of which 620,296 induced abortions were performed, and 103,648 women were treated for abortion-related complications. Hence, with the increasing rate of unintended pregnancies, there will be a rapid increase in the demand for contraceptive devices, which will ultimately drive market growth over the forecast period.
• Furthermore, there are countries and their respective governments that have identified the need to curb the growth of unwanted pregnancies and have started a great number of initiatives to educate and prevent the spread of unwanted abortions and pregnancies. The usage of contraceptive pills is one of them. The right to obtain and use contraceptives is part of the fundamental right to privacy guaranteed by the United States Constitution. For instance, the United States Agency for International Development (USAID) promotes and supports voluntary family planning and reproductive health initiatives in approximately 40 countries throughout the world. Thus, government initiatives are also promoting the use of contraceptive methods to avoid unnecessary births and abortions.
• Similarly, the private sector is also taking initiatives to increase the use of contraceptives. For instance, in September 2022, Unwanted 21, the regular oral contraceptive brand from Mankind Pharma, launched a multilingual campaign on the occasion of World Contraception Day in India. The campaign was aimed at creating awareness about contraceptive options along with family planning. Therefore, such favorable government and private initiatives are anticipated to propel the market growth over the forecast period.
• However, the rising prevalence of infertility, lack of awareness, and adverse effects of contraceptive implants are likely to restrain the market growth.

Subdermal Contraceptive Implants Market Trends

Etonogestrel Implant Segment is Expected to Witness Considerable Growth Over the Forecast Period

Subdermal Contraceptive Implants Industry Segmentation

Subdermal contraceptive implants refer to those implants which involve the delivery of a steroid progestin from polymer capsules or rods placed under the skin. The hormone diffuses out slowly at a stable rate, providing contraceptive effectiveness for 1-5 years.

The subdermal contraceptive implants market is segmented by type (etonogestrel implant and levonorgestrel implant) and geography (North America, Europe, Asia-Pacific, and Rest of the World). The market report also covers the estimated market sizes and trends for 16 different countries across major regions globally.

The report offers the value (in USD) for the above segments.